Compass Therapeutics(CMPX)
Focus: Compass Therapeutics is a Boston-based public biotech focused on antibody therapies for oncology and neurology, currently in early-stage clinical development with minimal revenue.
Profile data last refreshed 5h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Compass Therapeutics?
AI assessmentCompass presents a high-risk, pre-revenue opportunity best suited for scientists willing to bet on psychedelic psychiatry and antibody oncology but should expect financial volatility and limited near-term stability.
Why Work Here
- Public company status provides liquidity and stability versus private biotech, with ticker CMPX offering equity upside potential
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$850K
Pipeline & Clinical Trials
Enhanced DBT-A
SuicidalityClinical Trials (1)
NCT07256496Enhanced Dialectical Behavior Therapy for Adolescents
N/AHelp build intelligence for Compass Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.